109 related articles for article (PubMed ID: 21807936)
1. PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer.
Johnson EO; Chang KH; de Pablo Y; Ghosh S; Mehta R; Badve S; Shah K
J Cell Sci; 2011 Aug; 124(Pt 16):2711-22. PubMed ID: 21807936
[TBL] [Abstract][Full Text] [Related]
2. LIMK2 is a crucial regulator and effector of Aurora-A-kinase-mediated malignancy.
Johnson EO; Chang KH; Ghosh S; Venkatesh C; Giger K; Low PS; Shah K
J Cell Sci; 2012 Mar; 125(Pt 5):1204-16. PubMed ID: 22492986
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
Nagai MA; Fregnani JH; Netto MM; Brentani MM; Soares FA
Breast Cancer Res Treat; 2007 Nov; 106(1):49-56. PubMed ID: 17211533
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of the PHLDA1 gene in IMR-32 neuroblastoma cells increases levels of Aurora A, TRKB and affects proteins involved in apoptosis and autophagy pathways.
Durbas M; Horwacik I; Boratyn E; Rokita H
Int J Oncol; 2016 Aug; 49(2):823-37. PubMed ID: 27278006
[TBL] [Abstract][Full Text] [Related]
5. Regional cyclin D1 overexpression or hypoxia correlate inversely with heterogeneous oestrogen receptor-alpha expression in human breast cancer.
Kronblad A; Helczynska K; Nielsen NH; Påhlman E; Emdin S; Påhlman S; Landberg G
In Vivo; 2003; 17(4):311-8. PubMed ID: 12929585
[TBL] [Abstract][Full Text] [Related]
6. PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheres.
Kastrati I; Canestrari E; Frasor J
Oncogene; 2015 Apr; 34(18):2309-16. PubMed ID: 24954507
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line.
Wang XX; Liu R; Jin SQ; Fan FY; Zhan QM
Cell Res; 2006 Apr; 16(4):356-66. PubMed ID: 16617331
[TBL] [Abstract][Full Text] [Related]
8. Aurora-A kinase phosphorylation of Aurora-A kinase interacting protein (AIP) and stabilization of the enzyme-substrate complex.
Katayama H; Sasai K; Czerniak BA; Carter JL; Sen S
J Cell Biochem; 2007 Dec; 102(5):1318-31. PubMed ID: 17957726
[TBL] [Abstract][Full Text] [Related]
9. Differential susceptibility to hydrogen sulfide-induced apoptosis between PHLDA1-overexpressing oral cancer cell lines and oral keratinocytes: role of PHLDA1 as an apoptosis suppressor.
Murata T; Sato T; Kamoda T; Moriyama H; Kumazawa Y; Hanada N
Exp Cell Res; 2014 Jan; 320(2):247-57. PubMed ID: 24270013
[TBL] [Abstract][Full Text] [Related]
10. Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma.
Kurai M; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Suzuki A; Konishi I
Hum Pathol; 2005 Dec; 36(12):1281-8. PubMed ID: 16311121
[TBL] [Abstract][Full Text] [Related]
11. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
Park SS; Kim SW
Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule inhibition of Aurora kinases triggers spindle checkpoint-independent apoptosis in cancer cells.
Sun L; Li D; Dong X; Yu H; Dong JT; Zhang C; Lu X; Zhou J
Biochem Pharmacol; 2008 Mar; 75(5):1027-34. PubMed ID: 18163976
[TBL] [Abstract][Full Text] [Related]
13. EWS-Fli1 up-regulates expression of the Aurora A and Aurora B kinases.
Wakahara K; Ohno T; Kimura M; Masuda T; Nozawa S; Dohjima T; Yamamoto T; Nagano A; Kawai G; Matsuhashi A; Saitoh M; Takigami I; Okano Y; Shimizu K
Mol Cancer Res; 2008 Dec; 6(12):1937-45. PubMed ID: 19074838
[TBL] [Abstract][Full Text] [Related]
14. Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype.
Baba F; Swartz K; van Buren R; Eickhoff J; Zhang Y; Wolberg W; Friedl A
Breast Cancer Res Treat; 2006 Jul; 98(1):91-8. PubMed ID: 16636895
[TBL] [Abstract][Full Text] [Related]
15. Aurora-A interacts with Cyclin B1 and enhances its stability.
Qin L; Tong T; Song Y; Xue L; Fan F; Zhan Q
Cancer Lett; 2009 Mar; 275(1):77-85. PubMed ID: 19028417
[TBL] [Abstract][Full Text] [Related]
16. PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells.
Bonatto N; Carlini MJ; de Bessa Garcia SA; Nagai MA
Cell Adh Migr; 2018 Jan; 12(1):37-46. PubMed ID: 28640659
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic role of nuclear accumulated Aurora-A.
Tatsuka M; Sato S; Kanda A; Miki T; Kamata N; Kitajima S; Kudo Y; Takata T
Mol Carcinog; 2009 Sep; 48(9):810-20. PubMed ID: 19204928
[TBL] [Abstract][Full Text] [Related]
18. Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation.
Neef R; Kuske MA; Pröls E; Johnson JP
Cancer Res; 2002 Oct; 62(20):5920-9. PubMed ID: 12384558
[TBL] [Abstract][Full Text] [Related]
19. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
20. Node negative breast carcinoma: hyperprolactinemia and/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators.
Patel DD; Bhatavdekar JM; Chikhlikar PR; Ghosh N; Suthar TP; Shah NG; Mehta RH; Balar DB
J Surg Oncol; 1996 Jun; 62(2):86-92. PubMed ID: 8649046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
